STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Healthcare Pharmaceuticals
scientist

Telomir Pharmaceuticals Achieves Breakthrough in Silver-Based Medical Science

byLuca Blaumann
February 20, 2025
in Pharmaceuticals, Small-Cap
Reading Time: 3 mins read
Share on TwitterShare on LinkedIn

Stabilizing Silver(II) for Enhanced Antimicrobial and Wound Healing Applications

Telomir Pharmaceuticals (TELO) has announced a groundbreaking scientific achievement—its proprietary compound, Telomir-1, has successfully stabilized Silver(II) (Ag²⁺) in a biologically compatible form. This milestone overcomes a major challenge in silver-based medicine, unlocking new possibilities for advanced antimicrobial treatments, wound care solutions, and infection-resistant medical coatings.

Revolutionizing Silver-Based Medicine

Silver has long been valued in medical applications for its potent antimicrobial properties, with Silver(I) (Ag⁺) commonly used in wound dressings and medical coatings. However, Silver(II) (Ag²⁺), which offers significantly greater oxidative capacity and bactericidal activity, has remained largely untapped due to its extreme instability. Telomir’s breakthrough stabilizes Silver(II), enabling its safe and effective use in healthcare for the first time.

The implications are substantial, as the silver-based medical market is rapidly growing. The silver wound dressings market, valued at $1.03 billion in 2024, is projected to reach $1.36 billion by 2030. Additionally, the antimicrobial coatings market—which includes silver-infused medical devices, hospital surfaces, and implants—is expected to grow from $11.65 billion in 2024 to $33.7 billion by 2031, at a CAGR of 14.2%.

Why Silver(II) is Superior for Healing and Infection Control

Silver(II) offers several advantages over traditional Silver(I) in medical applications:

  • More Potent Antimicrobial Action: Silver(II) is a stronger oxidizing agent, meaning it can penetrate biofilms and effectively combat antibiotic-resistant bacteria.
  • Accelerated Wound Healing: Studies suggest that Silver(II) can stimulate fibroblast activity, enhance collagen production, and upregulate vascular endothelial growth factor (VEGF), improving tissue regeneration.
  • Anti-Inflammatory and Immune Modulation: Silver(II) may help balance immune responses and reduce excessive inflammation, making it particularly beneficial for chronic wounds and post-surgical recovery.

Despite these benefits, the medical community has struggled to incorporate Silver(II) into treatments due to its rapid degradation—until now.

Telomir’s Solution: Stabilizing Silver(II) for Medical Use

Previous attempts to stabilize Silver(II) relied on chemical methods such as fluorosulfates and heterocyclic amines, which proved unsuitable for biological applications due to toxicity and instability. Telomir-1 offers a breakthrough alternative, potentially serving as the first biologically compatible carrier to stabilize Silver(II) for medical applications.

Expanding Applications in Modern Healthcare

Telomir-1’s ability to stabilize both Silver(I) and Silver(II) could lead to the development of:

  • Enhanced wound care solutions for burns, chronic wounds, and diabetic ulcers.
  • Advanced antimicrobial coatings for hospital equipment, implants, and catheters, reducing infection risks.
  • Next-generation silver-based therapeutics that leverage Silver(II)’s superior bactericidal and healing properties.

A Multi-Billion-Dollar Market Opportunity

“The ability to stabilize Silver(II) in a biologically relevant way is a game-changing scientific achievement,” said Erez Aminov, Chairman & CEO of Telomir. “This discovery expands Telomir-1’s applications beyond aging science and into high-value medical markets that were previously unattainable.”

Telomir is now advancing research into clinical applications and evaluating regulatory pathways to bring these innovations to market, potentially reshaping silver-based medicine.

You might like this article:Alibaba Surges on Strong Earnings, International Growth, and AI Investments

Tags: GrowthMoversNewsStock MarketTELOTelomir
Previous Post

Alibaba Surges on Strong Earnings, International Growth, and AI Investments

Next Post

Rivian Reports Record Revenue and Positive Gross Profit in Q4

Related Posts

KULR Technology Secures $14.8 Million Purchase Order for Advanced Energy Storage Systems

byLiliana Vida
November 18, 2026
0

New KULR ONE Max order strengthens the company's energy storage portfolio, with deliveries scheduled through 2027. KULR Technology Group (NYSE:...

KULR Technology Revenue Surges 197% in Q3 as Battery Sales Nearly Quadruple

byLuca Blaumann
November 10, 2026
0

Company reports $7.4 million in quarterly revenue, exits Bitcoin holdings, and strengthens its balance sheet with $54.5 million in cash...

KULR Secures $1 Million-Plus Battery Orders for U.S. Drone Dominance Program

byLuca Blaumann
October 1, 2026
0

Production orders strengthen KULR’s position in advanced drone systems, with deliveries scheduled through November 2026 KULR Technology Group (KULR) announced...

Next Post
Rivian Electric Pickup Truck

Rivian Reports Record Revenue and Positive Gross Profit in Q4

Latest News

Anthropic Leveraged ETFs: What GraniteShares’ AIL and ANS Offer Traders

KULR Technology Secures $14.8 Million Purchase Order for Advanced Energy Storage Systems

SELLAS Life Sciences Stock Soars 170% Following Positive Phase 3 Leukemia Vaccine Results

Qualcomm CEO Rejects AI Market Correction Fears as Company Expands Into Data Centers

D-Wave Quantum Q3 Revenue Climbs 21% as Backlog Surges Over 1,200%

Based on Your Interest

Artificial Intelligence

CoreWeave Q3 Revenue Surges Nearly 170% to $3.66 Billion as AI Demand Accelerates

November 11, 2026
Artificial Intelligence

CoreWeave Earnings Preview: Why Guidance Matters More Than Q3 Results

November 10, 2026
investing
Artificial Intelligence

D-Wave Quantum Q3 Revenue Rises 21% as Bookings Surge and Quantum Adoption Expands

November 10, 2026

Recommended

Auto Manufacturers

Lucid Secures $1.75 Billion Liquidity Boost From Saudi PIF to Support Turnaround

November 10, 2026
Artificial Intelligence

KULR Technology Revenue Surges 197% in Q3 as Battery Sales Nearly Quadruple

November 10, 2026
Aerospace & Defense

Rocket Lab Q3 Revenue Surges 73% to $268 Million, Beating Wall Street Expectations

November 9, 2026
Artificial Intelligence

IonQ Shares Climb as Company Expands Government Reach Through Carahsoft Partnership

November 9, 2026
Aerospace & Defense

AST SpaceMobile and Rakuten Launch Joint Venture Backed by $1 Billion in Japanese Government Funding

November 9, 2026
Stoxpo

Follow us on social media:

Highlights

  • Anthropic Leveraged ETFs: What GraniteShares’ AIL and ANS Offer Traders
  • KULR Technology Secures $14.8 Million Purchase Order for Advanced Energy Storage Systems
  • SELLAS Life Sciences Stock Soars 170% Following Positive Phase 3 Leukemia Vaccine Results
  • Qualcomm CEO Rejects AI Market Correction Fears as Company Expands Into Data Centers
  • D-Wave Quantum Q3 Revenue Climbs 21% as Backlog Surges Over 1,200%

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

Anthropic Leveraged ETFs: What GraniteShares’ AIL and ANS Offer Traders

November 20, 2026

KULR Technology Secures $14.8 Million Purchase Order for Advanced Energy Storage Systems

November 18, 2026
chemistry-2

SELLAS Life Sciences Stock Soars 170% Following Positive Phase 3 Leukemia Vaccine Results

November 17, 2026
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.